A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma

Journal of Cosmetic Dermatology

Volumn 6, Issue 1, 2007, Pages 36-39

  Ferreira Cestari, Tania ^a,e   Hassun, Karime ^b   Sittart, Alexandre ^c   de Lourdes Viegas, Maria ^d  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^d HOSPITAL DA LAGOA   (Brazil)

^e NONE   (Brazil)

Author keywords

Facial melasma; Fluocinolone acetonide; Hydroquinone; Stable fixed combination; topical therapy; tretinoin

Indexed keywords

CLARIPEL; FLUOCINOLONE ACETONIDE; FLUOCINOLONE ACETONIDE PLUS HYDROQUINONE PLUS RETINOIC ACID; HYDROQUINONE; RETINOIC ACID; TRI LUMA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURNING SENSATION; CHLOASMA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SKIN ATROPHY; SYSTEMIC DISEASE; TELANGIECTASIA;

ADMINISTRATION, TOPICAL; ADULT; DRUG COMBINATIONS; EMOLLIENTS; FACIAL DERMATOSES; FEMALE; FLUOCINOLONE ACETONIDE; FOLLOW-UP STUDIES; HUMANS; HYDROQUINONES; MALE; MELANOSIS; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRETINOIN;

EID: 33847789809     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2007.00288.x     Document Type: Article

References (19)

1. Grimes PE. Melasma: Etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453-7.
2. Mosher DB, Fitzpatrick TB, Ortonne J-P, Hori Y. Hypomelanoses and hypermelanoses. In: IM Freedberg, AZ Eisen, K Wolff et al., eds. Fitzpatrick's Dermatology in General Medicine, Vol. 1. New York: McGraw-Hill; 1999: 945-1017.
3. Barankin B, Silver SG, Carruthera A. The skin in pregnancy. J Cut Med Surg 2002; 6: 236-40.
4. Sober AF, Fitzpatrick TB. Disturbances of pigmentation. Section I. Mechanisms of pigmentation in man. In: SL Moschella, DM Pillsbury, HJ Hurley Jr, eds. Dermatology, Vol. 2. Philadelphia: W.B. Saunders Co; 1975: 1085.
5. Vasquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men. Int J Dermatol 1988; 27: 25-7.
6. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermato 1986; 15: 894-9.
7. Giannotti B, Melli MC. Current approaches to the treatment of melasma. Clin Drug Invest 1995; 0 (Suppl. 2): 57-64.
8. Griffiths CEM, Finkel LJ, Ditre CM et al. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 1993; 129: 415-21.
9. Verallo-Rowell VM, Verallo V, Graupe K et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol 1989; 143 (Suppl.): 58-61.
10. Sanchez JL, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol 1982; 20: 55-8.
11. Kimbrough-Green CK, Griffiths CEM, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol 1994; 130: 727-33.
12. Gano SE, Garcia RL. Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma. Cutis 1979; 23: 239-41.
13. Kang WH, Chun SC, Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): Clinical and histological studies. J Dermatol 1998; 25: 587-96.
14. Katsambas A, Antoniou Ch. Melasma: Classification and treatment. J Eur Acad Dermatol Venereol 1995; 4: 217-23.
15. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975; 111: 40-8.
16. Kligman LH, Schwartz E, Lesnik RH, Mezick JA. Topical tretinoin prevents corticosteroid-induced atrophy without lessening the anti-inflammatory effect. Curr Probl Dermatol 1993; 21: 79-88.
17. McMichael AJ, Griffiths CE, Talwar HS et al. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy. Br J Dermatol 1996; 135: 60-4.
18. Taylor S, Torok H, Jones T et al. Efficacy and safety of a new triple combination agent for the treatment of facial melasma. Cutis 2003; 72: 67-72.
19. Torok H, Taylor S, Baumann LM et al. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol 2005; 4: 592-7.